Endonovo Therapeutics, Inc.
OTC: ENDV0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Alan Brian Collier
- Employees
- 1
- Headquarters
- Woodland Hills, United States
- IPO year
- 2012
- Market cap
- $31.9K
- Website
- https://www.endonovo.com
Loading ENDV…
Loading profile data…Frequently asked questions about ENDV
What does Endonovo Therapeutics, Inc. (ENDV) do?
Endonovo Therapeutics, Inc., a biotechnology company, specializes in the development, manufacturing, and distribution of non-invasive electroceutical medical devices designed for regenerative medicine applications. The company's primary offering is SofPulse, an advanced non-invasive therapeutic device that employs electroceutical technology. Sof...
Where does ENDV trade?
Endonovo Therapeutics, Inc. (ENDV) trades on the Other OTC.
What sector is ENDV in?
Endonovo Therapeutics, Inc. (ENDV) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Endonovo Therapeutics, Inc.?
Alan Brian Collier is the chief executive officer of Endonovo Therapeutics, Inc. (ENDV).
Where is Endonovo Therapeutics, Inc. headquartered?
Endonovo Therapeutics, Inc. is headquartered in United States.
Does ENDV pay a dividend?
Endonovo Therapeutics, Inc. (ENDV) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ENDV go public?
Endonovo Therapeutics, Inc. (ENDV) completed its initial public offering in 2012.